Oncobeta logo

Efficacy, Safety and Patient Experiences of Rhenium-SCT® for Non-Melanoma Skin Cancer

To read the full published manuscript, visit: https://www.advancesradonc.org/article/S2452-1094(25)00089-2/fulltext

DOWNLOAD

Subscribe to Our Newsletter


Privacy Collection Notice:
OncoBeta Therapeutics Pty Ltd collects the personal information you provide in this form to send you the referring clinicians guide and to better understand the needs of our clinical audience.

If you agree below, we will also use your contact details to send you news, updates, and marketing communications. We handle your information securely and in accordance with our Privacy Policy. Providing your name and email is necessary to receive the guide, while all other fields are optional. You can unsubscribe from our marketing communications at any time.

We handle your information securely and in accordance with our Privacy Policy.

Phone : +61 (0)7 3012 6343

Email : admin-au@oncobeta.com

Patients

Healthcare Professionals

Rhenium-SCT®

Company

Acknowledgement
We acknowledge the cultures of our First Nations Peoples and are thankful for the community that we share together now. We pay our respects to our First Nations Peoples and their elders, both past,  present, and those who are rising up to become leaders.

Consent Preferences

© 2026 Oncobeta Therapeutics Pty Ltd. All Rights Reserved.